论文部分内容阅读
本文报告用硫酸亚铁0.3g/日治疗的缺铁性贫血(简称 IDA)患者,其效果同常规量(0.9～1.8g/日),副作用显著降低,现整理报告如下。30例 IDA 符合以下标准:①Hb 男<12g%,女<11g%;②血清铁蛋白(SF)<(14ng/ml;③铁剂治疗后 Hb 恢复正常。男3例,女27例,年龄25±9.98((?)±SD)岁,出现症状至治疗时的病程为20天～20年,<3年者23例,慢性失血27例,乏胃酸2例,偏食1例。将患者随机等分成三组:①每日单服硫酸亚铁0.3g 为 A 组;②并常规量 VitC 和胃蛋白酶合剂者为 B 组;③硫酸亚铁0.9/日并常规量 vitc 和胃
This article reports the use of 0.3g / day ferrous sulfate treatment of iron deficiency anemia (IDA) patients with the same effect (0.9 ~ 1.8g / day), side effects were significantly reduced, the report is now organized as follows. 30 cases of IDA meet the following criteria: ① Hb male <12g%, female <11g%; ② serum ferritin (SF) <14ng / ml; ③ Hb iron normalization returned to normal after 3 males and 27 females, age 25 ± 9.98 ((±) SD), the course of symptoms was 20 to 20 years, 23 cases of <3 years, 27 cases of chronic blood loss, 2 cases of gastric acidosis, 1 partial ejaculation. Divided into three groups: ① daily single serving of ferrous sulfate 0.3g for the A group; ② and regular doses of VitC and pepsin mixture were B group; ③ ferrous sulfate 0.9 / day and conventional vitc and stomach